Gamma-butyrolactone

Gamma-butyrolactone is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 14993 references associated with Gamma-butyrolactone in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for Gamma-butyrolactone

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Gamma-butyrolactone

MeSH term MeSH ID Detail
Stomach Ulcer D013276 75 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Ataxia D001259 20 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Weight Loss D015431 56 associated lipids
Total 9

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with Gamma-butyrolactone

Download all related citations
Per page 10 20 50 100 | Total 3467
Authors Title Published Journal PubMed Link
Zhu J et al. AvaR2, a pseudo γ-butyrolactone receptor homologue from Streptomyces avermitilis, is a pleiotropic repressor of avermectin and avenolide biosynthesis and cell growth. 2016 Mol. Microbiol. pmid:27502190
Zhang C et al. Characterization of N-acyl homoserine lactones (AHLs) producing bacteria isolated from vacuum-packaged refrigerated turbot (Scophthalmus maximus) and possible influence of exogenous AHLs on bacterial phenotype. 2016 J. Gen. Appl. Microbiol. pmid:27118073
Zeng J et al. Mechanism of azithromycin inhibition of HSL synthesis in Pseudomonas aeruginosa. 2016 Sci Rep pmid:27075730
Cheema AK et al. Chemopreventive Metabolites Are Correlated with a Change in Intestinal Microbiota Measured in A-T Mice and Decreased Carcinogenesis. 2016 PLoS ONE pmid:27073845
Singh N et al. Inhibition of fatty acid synthase is protective in pulmonary hypertension. 2016 Br. J. Pharmacol. pmid:27061087
Holm A et al. Pseudomonas aeruginosa N-3-oxo-dodecanoyl-homoserine Lactone Elicits Changes in Cell Volume, Morphology, and AQP9 Characteristics in Macrophages. 2016 Front Cell Infect Microbiol pmid:27047801
Slebe F et al. FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth. 2016 Nat Commun pmid:27045898
Hu PY et al. Elucidation of Transport Mechanism of Paeoniflorin and the Influence of Ligustilide, Senkyunolide I and Senkyunolide A on Paeoniflorin Transport through Mdck-Mdr1 Cells as Blood-Brain Barrier in Vitro Model. 2016 Molecules pmid:26950101
Kuncewitch M et al. Inhibition of fatty acid synthase with C75 decreases organ injury after hemorrhagic shock. 2016 Surgery pmid:26372196
Tamura M et al. Effects of an equol-producing bacterium isolated from human faeces on isoflavone and lignan metabolism in mice. 2016 J. Sci. Food Agric. pmid:26455424